companydata.dkcompanydata.dk

AVP BioPharma Consult ApS: Financial statements 2022

CVR: 37770426

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

AVP BioPharma Consult ApS (CVR 37770426) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,125,468 and a net result of DKK 148,392 compared with DKK 260,721 the year before. That is a decrease of 6.3% compared with the year before. Equity in the 2022 report amounted to DKK 294,089. The solvency ratio was 59%. The company had 1 employee in the financial year.

Gross Profit
DKK 1,125,468
Profit/Loss
DKK 148,392
Equity
DKK 294,089
Total Assets
DKK 498,486
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-1.1M148K294K1
2021-1.2M261K346K1
2020-1.1M190K295K1
2019-1.5M320K375K1
2018-1M71K126K1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on AVP BioPharma Consult ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

AVP BioPharma Consult ApS: The 2021 annual report is outMar 21, 2022

AVP BioPharma Consult ApS has published its annual report for 2021. Gross profit came to DKK 1,201,153, and the net result was DKK 260,721.

About AVP BioPharma Consult ApS

AVP BioPharma Consult ApS is a Danish company of the type Anpartsselskab based in Virum, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Vagnø Pedersen. The company is owned by AVP Holdings ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,249,151 and a net result of DKK 247,464 compared with DKK 237,789 the year before. Equity in the 2025 report amounted to DKK 320,541.

Source: annual report 2025, Danish Business Authority